MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2024 All rights reserved. Tickeron Inc.

ARTH Arch Therapeutics, Inc. Forecast, Technical & Fundamental Analysis

Industry Biotechnology
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
Ad is loading...
A.I. Advisor
published Earnings

ARTH is expected to report earnings to fall 20,100.00% to $2.00 per share on March 01

Arch Therapeutics, Inc. ARTH Stock Earnings Reports
Q4'22
Est.
$2.00
Q3'22
Est.
$-0.01
Q2'22
Beat
by $0.01
Q1'22
Beat
by $0.01
The last earnings report on November 30 showed earnings per share of 0 cents, meeting the estimate of 0 cents. With 461.00 shares outstanding, the current market capitalization sits at 2.22M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
235 Walnut Street
Phone
+1 617 431-2313
Employees
8
Web
https://www.archtherapeutics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL232.150.37
+0.16%
Apple
SPY582.350.05
+0.01%
SPDR® S&P 500® ETF Trust
TSLA220.89-0.44
-0.20%
Tesla
BTC.X67399.836000-212.882810
-0.31%
Bitcoin cryptocurrency
GME21.41-0.25
-1.15%
GameStop Corp

ARTH and Stocks

Correlation & Price change

A.I.dvisor tells us that ARTH and EDSA have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ARTH and EDSA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARTH
1D Price
Change %
ARTH100%
+51.16%
EDSA - ARTH
21%
Poorly correlated
+0.74%
APLIF - ARTH
10%
Poorly correlated
+6.87%
AGTX - ARTH
6%
Poorly correlated
N/A
BETRF - ARTH
6%
Poorly correlated
N/A
BITRF - ARTH
4%
Poorly correlated
N/A
More